Enzyme-Responsive Targeted Nanomedicines: A Novel Strategy for Cancer Therapy

Key Points

• The aim is to explore enzyme-responsive targeted nanomedicines for precise cancer treatment based on tumor characteristics.
• Developed nanomedicine that responds to specific enzymes in the tumor microenvironment
• Assessed the effectiveness of the targeted approach in localized drug delivery
• Compared traditional therapies with enzyme-responsive systems
• Significantly improved drug concentration at tumor sites compared to non-targeted methods
• Demonstrated reduced side effects due to localized delivery
• Enhanced therapeutic outcomes in treated models